On April 5, 2019, Alex Katz resigned as Chief Financial Officer of CURE Pharmaceutical Holding Corp. (the Company), effective immediately. Mark Udell, the Company's current Chief Accounting Officer, Treasurer and Secretary will serve as the Company's Principal Financial Officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0389 USD | -0.26% | 0.00% | -47.72% |
1st Jan change | Capi. | |
---|---|---|
-47.72% | 28.55L | |
+14.23% | 3,19800Cr | |
+12.38% | 9.01TCr | |
+6.81% | 8.06TCr | |
-14.00% | 5.48TCr | |
+21.23% | 4.69TCr | |
+32.35% | 4.65TCr | |
-32.01% | 4.29TCr | |
+67.25% | 4TCr | |
-2.24% | 2.69TCr |
- Stock Market
- Equities
- AVRW Stock
- News Avenir Wellness Solutions, Inc.
- CURE Pharmaceutical Holding Corp. Announces Executive Changes